SAN DIEGO, Sept. 17, 2018 /PRNewswire/ -- Lin BioScience, a drug development company targeting untreatable conditions in oncology, ophthalmology and metabolic diseases, announced today that the US Food and Drug
Growth Capitalist (https://growthcapitalist.com/2018/09/fda-grants-lin-bioscience-rare-pediatric-disease-status-for-lbs-008-to-treat-stargardt-disease/)
SAN DIEGO, Sept. 17, 2018 /PRNewswire/ -- Lin BioScience, a drug development company targeting untreatable conditions in oncology, ophthalmology and metabolic diseases, announced today that the US Food and Drug